British Discover “Trojan Horse” Anti-cancer Treatment – IOTW Report

British Discover “Trojan Horse” Anti-cancer Treatment

The Institute of Cancer Research in London and the Royal Marsden NHS Foundation Trust (London) have released the findings of an experimental treatment that delivers a cancer fighting drug,  tisotumab vedotin (TV), into the diseased cells themselves.

The TV treatment is made up of a toxic drug attached to an antibody and designed to target a receptor, found in high levels on the surface of many cancer cells, called tissue factor.

When it binds to the tissue factor, the drug is able to get inside cancer cells to kill them from within.

About a quarter of the cervical and bladder cancer patients had positive results with the new treatment regime on their drug-resistant disease.

More

8 Comments on British Discover “Trojan Horse” Anti-cancer Treatment

  1. I worked for a pharma research company in early 2000’s which developed a novel delivery method for an anti-cancer drug which used albumin, a basic protein. The cancer cells would eat it up only to find the drug inside. The challenge was making it – took years to develop. I think it cost $5,000 a vial and you needed several vials. It was quite effective, and easier on the patient than the previous version of the drug that had it suspended in a toxic substance.

    5
  2. I miss the days when the trade and pharmaceutical names made sense and had to do with their chemistry or their function. Now they all sound like pig latin or toddler talk.

    2

Comments are closed.